Finding blood in the dark: A comparison of infrared imaging devices for the detection of bloodstains on dark fabrics based on their resolution.

The use of infrared (IR) light to locate bloodstains on dark fabric is a search technique that is employed in forensic examinations in a number of organisations worldwide. IR is used to complement existing, established visual white light search techniques. There exist a variety of commercially available products that can be purchased for this purpose as well as the option of using IR-converted standard DSLR (Digital Single Lens Reflex) cameras. In this study, a number of IR systems with contrasting resolutions were explored and their performance was assessed on a variety of bloodstain types and fabrics in comparison with white light. The systems ranged from low-budget, low resolution options, such as portable webcams, to vision-industry standard, high resolution, purpose-built cameras for more detailed blood searching of suitable items in the laboratory. Blood spatter, transfer bloodstains, dilute bloodstains, blood mixed with other body fluids and environmental contaminants were among the samples tested on eight different dark fabric types under IR conditions to assess the impact of the resolution differences. All IR systems were able to locate bloodstains, with significantly more bloodstains being found with IR compared to white light. The higher resolution systems were able to locate significantly more bloodstains than the systems with the lower resolution. The webcams were able to locate many of the larger areas of bloodstaining but performed less well in terms of locating smaller bloodstains and dilute blood. False positives such as mud, make-up and brown sauce were detected under IR but were readily discriminated under white light and with presumptive chemical tests. The balance between the ability to locate bloodstains based on system resolution and practicality and possible efficiency gains is discussed.

Focussing on the future: survey results on the image capture of patterned cutaneous injuries.

An investigator who is involved in assessing the likelihood of physical abuse must make a decision as to whether the injury seen matches the explanation given. In some instances the pattern of these injuries can give the investigator a possible link to the cause of the injury. Photographic imaging is used to record the patterned cutaneous injuries (PCI) and to facilitate forensic interpretation. The current method of capturing PCI often results in some form of distortion that causes a change to the shape of the patterned injury. The Dermatological Patterned Injury Capture and Analysis (DePICA) research group was formed to assess current image capture methods and practices. An online survey was set up to assess the value of localised imaging protocols and training specific to imaging PCI and was made available to law enforcement professionals, forensic investigators and hospital staff. 80 participants responded to the survey. The majority of the survey participants have had training in medical or forensic photography, however 66 (83%) have not had specific training in how to photograph PCI. 41 (51%) of the participants responded that they always use a rigid scale and 34 (43%) position the camera so that it is perpendicular to the scale and injury. Comments made about the quality of images obtained and produced raises concerns about how much knowledge those initiating such images have about image relevance in criminal cases. It is evident that a clear and comprehensive guide to photographing PCIs is required to improve the quality of the photographic evidence that is collected.

Guidelines for photography of cutaneous marks and injuries: a multi-professional perspective.

Investigators assessing the likelihood of physical abuse, must make a decision as to whether the injury seen matches the explanation given. In some instances the pattern of these injuries can give the investigator a possible link to the cause of the injury. Thus, matching an injury pattern to an implement or weapon used has forensic implications. The current method of capturing patterned injuries together with poor scale placement often result in some form of distortion that causes a change to the shape of the patterned injury. The aim of this guideline is to assist individuals dealing with the capture of photographic evidence for the investigation of suspected non-accidental patterned cutaneous injuries (PCI), and to ensure high standards of image quality are met for both evidential records and for forensic analysis. The technical equipment specified within these guidelines are recommended by the authors as a basic requirement for imaging best practice, due to their ability to capture detailed and critical data. For precise pattern matching analysis, it is vital that both the injury and the suspected implement are photographed in accordance with this guidance.

CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy.

Glioblastomas are among the most aggressive human cancers, and prognosis remains poor despite presently available therapies. Angiogenesis is a hallmark of glioblastoma, and the resultant vascularity is associated with poor prognosis. The proteins that mediate angiogenesis, including vascular endothelial growth factor (VEGF) signaling proteins, have emerged as attractive targets for therapeutic development. Since VEGF receptor-2 (VEGFR-2) is thought to be the primary receptor mediating angiogenesis, direct inhibition of this receptor may produce an ideal therapeutic effect. In this context, we tested the therapeutic effect of CT322, a selective inhibitor of VEGFR-2. Using an intracranial murine xenograft model (U87-EGFRvIII-luciferase), we demonstrate that CT322 inhibited glioblastoma growth in vivo and prolonged survival. Of note, the anti-neoplastic effect of CT322 is augmented by the incorporation of temozolomide or temozolomide with radiation therapy. Immunohistochemical analysis of CT322 treated tumors revealed decreased CD31 staining, suggesting that the tumoricidal effect is mediated by inhibition of angiogenesis. These pre-clinical results provide the foundation to further understand long term response and tumor escape mechanisms to anti-angiogenic treatments on EGFR over-expressing glioblastomas.